Ekman Lars
SEC CIK 1376117 · EDGAR
BoughtSold
Most active insiders at PRTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SCULLY WILLIAM P | 10% | $4.96M | — |
| 2 | Isaacs Michael John | GC, Company Sec | — | $71.1K |
| 3 | Kingston Anne Evans | Chief Strategy Off | — | $64.9K |
| 4 | Swanson Chad J. | Chief Development Off | — | — |
| 5 | Smith Brandon S. | COO | — | — |
| 6 | Zago Wagner M. | CSO | — | — |
| 7 | Kinney Gene G. | Pres, CEO, Dir | — | — |
| 8 | Walker Karin L | CAO | — | — |
| 9 | Nguyen Tran | CFO, Chief Strategy Off | — | — |
Ekman Lars made no open-market trades at PRTA in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-05 | 2023-01-03 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | M - OptEx | $6.41 | +15.8K | 16.1K | +6,516% | +$101.5K |
| DM | 2023-01-05 | 2023-01-03 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | S - Sale+OE | $55.98 | -15.8K | 3,148 | -83% | -$886.4K |
| DM | 2022-12-02 | 2022-12-01 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | S - Sale+OE | $61.60 | -15.8K | 6,264 | -72% | -$975.4K |
| D | 2022-12-02 | 2022-12-01 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | M - OptEx | $6.41 | +15.8K | 16.1K | +6,516% | +$101.5K |
| D | 2022-11-03 | 2022-11-01 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | M - OptEx | $6.41 | +15.8K | 16.1K | +6,516% | +$101.5K |
| DM | 2022-11-03 | 2022-11-01 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | S - Sale+OE | $62.89 | -15.8K | 6,933 | -70% | -$995.7K |
| DM | 2022-10-05 | 2022-10-03 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | S - Sale+OE | $61.52 | -15.8K | 12.6K | -56% | -$974.1K |
| D | 2022-10-05 | 2022-10-03 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | M - OptEx | $6.41 | +15.8K | 16.1K | +6,516% | +$101.5K |
| D | 2022-09-30 | 2022-09-28 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | M - OptEx | $6.41 | +31.7K | 31.9K | +13,031% | +$203.0K |
| D | 2022-09-30 | 2022-09-28 | PRTA | PROTHENA CORP PUBLIC LTD CO | Ekman Lars | Dir, COB of the Board | S - Sale+OE | $48.09 | -31.7K | 243 | -99% | -$1.52M |
| D | 2022-06-28 | 2022-06-24 | RARE | Ultragenyx Pharmaceutical Inc. | Ekman Lars | Dir | A - Grant | $0.00 | +3,300 | 17.7K | +23% | $0 |
Purchase Sale Sale after option exercise All abbreviations